Principle Health Systems Acquires Telos PGX: A Strategic Move to Advance Personalized Healthcare
Principle Health Systems Acquires Telos PGX: A Strategic Move to Advance Personalized Healthcare
D.J. Hart will continue to play a pivotal role in the organization as he joins the leadership team at Principle Health Systems as the Director of Pharmacogenetic Operations. His deep understanding of the challenges faced by SNFs and his commitment to driving positive change will be instrumental in shaping the future of personalized medicine.ADDISON, Texas, Dec. 9, 2024 /PRNewswire/ -- Principle Health Systems, the leading mobile diagnostic provider for the long-term care community, is excited to announce its acquisition of Telos PGX, a pioneering force in pharmacogenetic testing. This strategic move will further accelerate Telos PGX's mission to revolutionize healthcare by providing personalized medication solutions.
德克萨斯州艾迪森，2024年12月9日 /PRNewswire/ -- Principle Health Systems，作为长期护理社区领先的移动诊断提供商，很高兴地宣布收购Telos PGX，这是一家在药物基因测试领域的先锋力量。这一战略举措将进一步加速Telos PGX的使命，即通过提供个性化的用药解决方案来彻底改变医疗保健。
Telos PGX has rapidly gained recognition for its proprietary Telos PGX Program, specifically designed to support Skilled Nursing Facilities (SNFs) and enhance patient care.
By leveraging advanced pharmacogenetic testing, Telos PGX empowers healthcare providers to make precise medication decisions, reducing adverse drug reactions and optimizing treatment plans.
Telos PGX因其专有的Telos PGX计划而迅速获得认可，该计划专为支持专业护理机构（SNFs）而设计，旨在提升患者护理。
通过利用先进的药物基因测试，Telos PGX使医疗保健提供者能够做出准确的用药决策，减少不良药物反应并优化治疗方案。
"We are thrilled to join forces with Principle Health Systems," said D.J. Hart, Founder and CEO of Telos PGX. "This transaction will provide us with the resources and expertise to scale our operations, accelerate innovation, and expand our reach. Together, we will transform the future of healthcare and improve the lives of countless patients."
“我们很高兴与Principle Health Systems携手合作，”Telos PGX的创始人兼首席执行官D.J. Hart说道。“这一交易将为我们提供扩展业务、加速创新和扩大影响力所需的资源和专业知识。我们将一起改变医疗保健的未来，提高无数患者的生活质量。”
D.J. Hart will continue to play a pivotal role in the organization as he joins the leadership team at Principle Health Systems as the Director of Pharmacogenetic Operations. His deep understanding of the challenges faced by SNFs and his commitment to driving positive change will be instrumental in shaping the future of personalized medicine.
D.J. Hart将继续在组织中发挥关键作用，他将作为药物基因操作董事加入Principle Health Systems的领导团队。他对专业护理机构面临的挑战深刻理解，以及他推动积极变革的承诺，将对塑造个性化医学的未来起到重要作用。
"Telos PGX's innovative approach to pharmacogenetic testing aligns perfectly with our vision to deliver advanced healthcare solutions," said James Dieter, CEO at Principle Health Systems. "By combining Principle's experience and resources with Telos's innovation, we will be able to accelerate the adoption of personalized medicine and improve patient outcomes."
“Telos PGX在药物基因测试方面的创新方法与我们提供先进医疗解决方案的愿景完全一致，”Principle Health Systems的首席执行官James Dieter说道。“通过将Principle的经验和资源与Telos的创新结合，我们将能够加速个性化医学的采用，改善患者结果。”
About Telos PGX:
Telos PGX is a leading provider of pharmacogenetic testing solutions in the LTC market. By analyzing an individual's genetic makeup, Telos PGX empowers healthcare providers to make informed medication decisions, improving patient outcomes and reducing healthcare costs.
关于Telos PGX：
Telos PGX是长期护理市场领先的药物基因测试解决方案提供商。通过分析个人的基因组成，Telos PGX使医疗保健提供者能够做出明智的用药决策，提高患者结果并降低医疗成本。
About Principle Health Systems:
Principle Health Systems is a healthcare innovation leader committed to improving patient outcomes and enhancing the quality of care. Through strategic partnerships and advanced technology, Principle Health Systems is transforming the healthcare landscape to help patients age in place.
关于原则健康系统：
原则健康系统是一家医疗创新领袖，致力于改善患者的结果和提升护理质量。通过战略合作伙伴关系和爱文思控股科技，原则健康系统正在转变医疗格局，帮助患者在家中安享晚年。
SOURCE Principle Health Systems
来源：原则健康系统
